Table 6.
Outcome | N | hPDI versus PDI statistical significance with outcome | hPDI versus uPDI statistical significance with outcome | Studies (references) | ||||
---|---|---|---|---|---|---|---|---|
Favors hPDI* | Both same† | Favors PDI‡ | Favors hPDI* | Both same† | Favors uPDI‡ | |||
Hypertension | 5 | 1 | 4 | 0 | 4 | 1 | 0 | (48, 49, 51, 57, 88) |
HDL cholesterol | 8 | 0 | 8 | 0 | 8 | 6 | 0 | (26, 34, 48, 65, 78, 90, 91, 99) |
LDL cholesterol | 5 | 0 | 5 | 0 | 0 | 4 | 1 | (26, 34, 65, 90, 99) |
Lip accumulation product | 1 | 0 | 1 | 0 | 0 | 1 | 0 | (88) |
Metabolic syndrome | 5 | 1 | 4 | 0 | 4 | 1 | 0 | (19, 47, 48, 66, 76) |
Non-HDL | 1 | 0 | 1 | 0 | 0 | 1 | 0 | (90) |
Systolic blood pressure | 4 | 1 | 3 | 0 | 1 | 3 | 0 | (15, 34, 65, 78) |
Diastolic blood pressure | 4 | 2 | 2 | 0 | 1 | 3 | 0 | (16, 34, 65, 78) |
Trimethylamine oxide | 1 | 0 | 0 | 1 | 0 | 0 | 1 | (40) |
Total cholesterol | 5 | 1 | 4 | 0 | 1 | 4 | 0 | (34, 65, 90, 91, 99) |
Total cholesterol/HDL | 1 | 1 | 1 | 0 | 1 | 1 | 0 | (65, 99) |
Triglycerides, high | 7 | 0 | 7 | 0 | 2 | 5 | 0 | (26, 34, 48, 65, 88, 90, 91) |
Triglyceride-glucose index | 1 | 0 | 1 | 0 | 0 | 1 | 0 | (88) |
Triglyceride/HDL | 1 | (65) | ||||||
Weight | 1 | 0 | 0 | 1 | 0 | 1 | 0 | (26) |
Waist circumference | 4 | 0 | 4 | 0 | 1 | 3 | 0 | (34, 78, 91, 99) |
Waist, hyper-triglycemic | 1 | 0 | 1 | 0 | 0 | 1 | 0 | (91) |
Glucose, high | 5 | 0 | 3 | 1 | 1 | 4 | 0 | (26, 34, 48, 65, 78, 88) |
HDL, high-density lipoprotein; LDL, low-density lipoprotein; PDI, plant-based dietary index; hPDI, healthful PDI; uPDI, unhealthful PDI. *Favors hPDI if hPDI hazard ratio statistical significance for the outcome is more favorable than the comparator (PDI or uPDI): e.g., hPDI significantly favorable and comparator non-significant or unfavorable, or hPDI non-significant and comparator unfavorable. †Both same if hPDI hazard ratio has same relationship to outcome as comparator (both significantly favorable, both non-significant, or both significantly unfavorable). ‡Favors comparator (PDI or uPDI) if hazard ratio statistical significance for the outcome is more favorable than the hPDI: e.g., comparator significantly favorable and hPDI non-significant or unfavorable, or comparator non-significant and hPDI unfavorable.